Schoorl M, Schoorl M, Bartels P C M
Department of Clinical Chemistry, Haematology & Immunology, Medical Center Alkmaar, The Netherlands.
Scand J Clin Lab Invest. 2008;68(4):335-42. doi: 10.1080/00365510701744481.
During haemodialysis treatment, blood flows from the body to the extracorporeal circuit and vice versa. In this study, pathophysiological defects in platelets indicated by alterations in RNA content and aberrations in platelet volume and morphology are detected before and during haemodialysis treatment. In subjects receiving haemodialysis treatment, qualitative interpretation of platelet characteristics with application of light microscopic evaluation reveals only 19+/-11 % of platelets with appropriate staining density of the granule-containing cytoplasm. On the contrary, a reference group of apparently healthy subjects shows 70+/-12 % platelets with appropriate staining density of the granule-containing cytoplasm. During haemodialysis treatment, mean values for platelet volume, platelet distribution width and platelet large cell ratio demonstrate a tendency to decrease by 10 %, 11 % and 6 %, respectively, from the mean initial value to the value at t = 150 min. Reduction of the platelet volume parameters just mentioned is hypothesized to be due to platelet degranulation as a result of platelet activation.
在血液透析治疗期间,血液从身体流入体外循环,反之亦然。在本研究中,在血液透析治疗之前和期间检测到血小板中RNA含量的改变以及血小板体积和形态异常所表明的病理生理缺陷。在接受血液透析治疗的受试者中,应用光学显微镜评估对血小板特征进行定性解释发现,只有19±11%的血小板含有颗粒的细胞质染色密度合适。相反,一组明显健康的受试者作为对照组,有70±12%的血小板含有颗粒的细胞质染色密度合适。在血液透析治疗期间,血小板体积、血小板分布宽度和血小板大细胞比率的平均值显示出从初始平均值到t = 150分钟时的值分别有下降10%、11%和6%的趋势。上述血小板体积参数的降低被推测是由于血小板活化导致的血小板脱颗粒所致。